Cometriq Interactions
There are 539 drugs known to interact with Cometriq (cabozantinib), along with 8 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 324 are major, 211 are moderate, and 4 are minor.
- View all 539 medications that may interact with Cometriq
- View Cometriq alcohol/food interactions (2)
- View Cometriq disease interactions (8)
Most frequently checked interactions
View interaction reports for Cometriq (cabozantinib) and the medicines listed below.
- acetaminophen / hydrocodone
- acetaminophen / oxycodone
- Advil (ibuprofen)
- Advil PM (diphenhydramine / ibuprofen)
- Afinitor (everolimus)
- Alcohol (contained in alcoholic beverages) (ethanol)
- Aldurazyme (laronidase)
- Alimta (pemetrexed)
- Allegra Allergy (fexofenadine)
- allopurinol
- amitriptyline
- Ampyra (dalfampridine)
- Anafranil (clomipramine)
- anastrozole
- Aptivus (tipranavir)
- Aranesp (darbepoetin alfa)
- Aredia (pamidronate)
- Arixtra (fondaparinux)
- atenolol
- Caprelsa (vandetanib)
- denosumab
- Gas-X (simethicone)
- ibuprofen
- levothyroxine
- ondansetron
- oxycodone
- Sandostatin LAR Depot (octreotide)
- sertraline
- trazodone
- zoledronic acid
Cometriq alcohol/food interactions
There are 2 alcohol/food interactions with Cometriq (cabozantinib).
Cometriq disease interactions
There are 8 disease interactions with Cometriq (cabozantinib) which include:
- hemorrhagic events
- GI perforation
- hepatic impairment
- hypertension
- renal impairment
- RPL syndrome
- thromboembolism
- lung toxicity
Report options
QR code containing a link to this page
More about Cometriq (cabozantinib)
- Cometriq consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.